Careteq (ASX:CTQ) Receivables Turnover: 0.06 (As of Dec. 2025)


What is Careteq Receivables Turnover?

Careteq ASX:CTQ Receivables Turnover is 0.06 as of Dec. 2025. The stock has 6 warning signs investors should review. Among 656 Healthcare Providers & Services companies, Careteq ranks worse than 81.71% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Careteq's Revenue for the six months ended in Dec. 2025 was A$0.05 Mil. Careteq's average Accounts Receivable for the six months ended in Dec. 2025 was A$0.88 Mil. Hence, Careteq's Receivables Turnover for the six months ended in Dec. 2025 was 0.06.


Careteq  (ASX:CTQ) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Careteq Receivables Turnover Related Terms


Careteq Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Careteq's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Careteq Receivables Turnover Chart

Careteq Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Receivables Turnover
0.00 10.20 16.59 15.74 23.21

Careteq Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only 3.49 2.44 4.68 5.54 0.06

ASX:CTQ vs VEEV, BTSG, TEM: Receivables Turnover Comparison

For the Health Information Services subindustry, Careteq's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Careteq Receivables Turnover vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Careteq's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Careteq's Receivables Turnover falls into.



Careteq Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Careteq's Receivables Turnover for the fiscal year that ended in Jun. 2025 is calculated as

Receivables Turnover (A: Jun. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Jun. 2025 ) / ((Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Jun. 2025 )) / count )
=7.624 / ((0.529 + 0.128) / 2 )
=7.624 / 0.3285
=23.21

Careteq's Receivables Turnover for the quarter that ended in Dec. 2025 is calculated as

Receivables Turnover (Q: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2025 ) / ((Accounts Receivable (Q: Jun. 2025 ) + Accounts Receivable (Q: Dec. 2025 )) / count )
=0.051 / ((0.128 + 1.63) / 2 )
=0.051 / 0.879
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.06 mean?
Careteq (ASX:CTQ) has a Receivables Turnover of 0.06 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Careteq and its competitors. According to the industry distribution chart, Careteq ranks #536 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 81.7%.
Is Careteq's Receivables Turnover too high?
Careteq's current Receivables Turnover is 0.06. The Healthcare Providers & Services industry median Receivables Turnover is 7.73. Careteq's value of 0.06 is 99.2% below this industry median. Based on the distribution chart, Careteq ranks #536 out of 656 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Careteq's Receivables Turnover compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Careteq ranks #536 out of 656 companies for Receivables Turnover. This places Careteq in the lower half of its industry. The industry median Receivables Turnover is 7.73. Careteq's value of 0.06 is 99.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.73, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Careteq's current Receivables Turnover of 0.06 is 99.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Careteq and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Careteq's current Receivables Turnover is 0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careteq stock overvalued right now?
Based on GuruFocus' analysis, Careteq (ASX:CTQ) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 20% above its estimated fair value. The current Receivables Turnover is 0.06 and 99.2% below the Healthcare Providers & Services industry median of 7.73. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Careteq (ASX:CTQ), the current Receivables Turnover is 0.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Careteq Business Description

Address 99 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
Careteq Ltd provides Residential Medication Management Review and Home Medicines Review services as part of the Medication Management Programs, generating revenue from medication review, education, and support services. The company focuses on medication management and home care solutions to provide continuity of care and improve clinical outcomes for patients through Home Medication Reviews. Medication-related harm includes adverse drug reactions, medication errors, and complications that jeopardise patient safety and increase healthcare costs. The company operates in Australia.